The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Dore, Fiona J.
Domingues, Cleyton C.
Amdur, Richard L.
Funding for this research was provided by:
Bristol-Myers Squibb Foundation
Text and Data Mining valid from 2018-05-03
11 February 2018
23 April 2018
3 May 2018